Associated Banc-Corp’s Novavax NVAX Stock Holding History

Associated Banc-Corp’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12	Closed	-$1K	–	673
2020 Q4	$1K	Hold	12	–	–	﹤0.01%	935
2020 Q3	$1K	Buy	+12	New	+$1.46K	﹤0.01%	903

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Associated Banc-Corp's NVAX Position: Q1 2021 in Review

Associated Banc-Corp sold out of Novavax (NVAX) in Q1 2021, closing a stake of 12 shares — an estimated $1K sold.

Associated Banc-Corp first reported a position in NVAX in Q3 2020 and held it in 2 quarters. The position peaked at $1K in Q4 2020. 389 funds tracked by Wall St. Rank hold NVAX as of Q1 2021.

Associated Banc-Corp reported no remaining Novavax position as of Q1 2021 after selling out during the quarter.
Associated Banc-Corp sold 12 Novavax shares in Q1 2021, an estimated $1K.
Associated Banc-Corp first reported a position in Novavax in Q3 2020 and held it in 2 quarters.
Associated Banc-Corp's Novavax position peaked at $1K in Q4 2020.
389 funds tracked by Wall St. Rank held Novavax as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.